gentile discordia investigatore crispr clinical trials punto morto Bagnato Corrispondenza
Eric Topol ar Twitter: "@techreview @JAMAOphth @emilylmullin @PNASNews @US_FDA @spark_tx Of the ongoing or planned #CRISPR clinical trials, 2 of 12 are for rare eye diseases https://t.co/i7GKOYTkPP" / Twitter
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics | Cancer Cell International | Full Text
China sprints ahead in CRISPR therapy race | Science
First clinical trial involving in vivo CRISPR human gene editing
CRISPR Therapeutics Plans First CRISPR Clinical Trial in Europe for 2018
Editas Wins FDA Approval for IND of CRISPR Treatment for LCA10
CRISPR-based therapeutics: The race is on - Pharmaceutical Technology
Genome editing technologies create buzz in medicine | EY Finland